An evaluation of Admedus' tissue engineering process-treated (ADAPT) bovine pericardium patch (CardioCel) for the repair of cardiac and vascular defects.
作者： Geoff Strange , Christian Brizard , Tom R Karl , Leon Neethling
DOI: 10.1586/17434440.2015.985651
关键词:
摘要: Tissue engineers have been seeking the ‘Holy Grail’ solution to calcification and cytotoxicity of implanted tissue for decades. Tissues with all desired qualities surgical repair congenital heart disease (CHD) are lacking. An anti-calcification engineering process (ADAPT® TEP) has developed applied bovine pericardium (BP) (CardioCel®, AdmedusRegen Pty Ltd, Perth, WA, Australia) eliminate cytotoxicity, improve resistance acute chronic inflammation, reduce facilitate controlled remodeling. Clinical data in pediatric patients, additional pre-market authorized prescriber demonstrate that CardioCel performs extremely well short term is safe effective a range deformations. These supported by animal studies which shown no more than normal physiologic levels calcification, good durability, biocompatibility healing.
uq.edu.au参考文章(24)
Ross Glancy, Andrew J Hodge, William M L Neethling, Sumit Yadav, Enhanced biostability and biocompatibility of decellularized bovine pericardium, crosslinked with an ultra-low concentration monomeric aldehyde and treated with ADAPT. Journal of Heart Valve Disease. ,vol. 17, pp. 456- 464 ,(2008)
Peta Clode, R. Glancy, A.J. Hodge, William Neethling, A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium. Journal of Cardiovascular Surgery. ,vol. 47, pp. 711- 718 ,(2006)
A.N. Smuts, D.C. Blaine, C. Scheffer, H. Weich, A.F. Doubell, K.H. Dellimore, Application of finite element analysis to the design of tissue leaflets for a percutaneous aortic valve. Journal of The Mechanical Behavior of Biomedical Materials. ,vol. 4, pp. 85- 98 ,(2011) , 10.1016/J.JMBBM.2010.09.009
Matthias Greutmann, Daniel Tobler, Changing epidemiology and mortality in adult congenital heart disease: looking into the future Future Cardiology. ,vol. 8, pp. 171- 177 ,(2012) , 10.2217/FCA.12.6
Teun van der Bom, A. Carla Zomer, Aeilko H. Zwinderman, Folkert J. Meijboom, Berto J. Bouma, Barbara J. M. Mulder, The changing epidemiology of congenital heart disease Nature Reviews Cardiology. ,vol. 8, pp. 50- 60 ,(2011) , 10.1038/NRCARDIO.2010.166
Seokwon Pok, Jeffrey G. Jacot, Biomaterials Advances in Patches for Congenital Heart Defect Repair Journal of Cardiovascular Translational Research. ,vol. 4, pp. 646- 654 ,(2011) , 10.1007/S12265-011-9289-8
Frederick J. Schoen, Charles E. Hobson, Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Human Pathology. ,vol. 16, pp. 549- 559 ,(1985) , 10.1016/S0046-8177(85)80103-9
Andrew S. Mackie, Louise Pilote, Raluca Ionescu-Ittu, Elham Rahme, Ariane J. Marelli, Health care resource utilization in adults with congenital heart disease American Journal of Cardiology. ,vol. 99, pp. 839- 843 ,(2007) , 10.1016/J.AMJCARD.2006.10.054
Ariane J. Marelli, Andrew S. Mackie, Raluca Ionescu-Ittu, Elham Rahme, Louise Pilote, Congenital Heart Disease in the General Population Changing Prevalence and Age Distribution Circulation. ,vol. 115, pp. 163- 172 ,(2006) , 10.1161/CIRCULATIONAHA.106.627224
Sameh M. Said, Joseph A. Dearani, Strategies for high-risk reoperations in congenital heart disease. Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual. ,vol. 17, pp. 9- 21 ,(2014) , 10.1053/J.PCSU.2014.01.004